Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.335
+0.105 (8.54%)
Aug 15, 2025, 10:44 AM - Market open

PACB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
54.855.37179.91325.09460.7381.61
Upgrade
Short-Term Investments
259.93334.56451.51447.23583.68237.2
Upgrade
Cash & Short-Term Investments
314.74389.93631.42772.321,044318.81
Upgrade
Cash Growth
-38.26%-38.25%-18.24%-26.05%227.59%549.33%
Upgrade
Accounts Receivable
32.2627.5236.6218.7924.2416.84
Upgrade
Receivables
32.2627.5236.6218.7924.2416.84
Upgrade
Inventory
53.8458.7656.6850.3824.614.23
Upgrade
Prepaid Expenses
12.2714.7817.0410.297.394.87
Upgrade
Restricted Cash
0.30.690.30.30.50.84
Upgrade
Other Current Assets
-4----
Upgrade
Total Current Assets
413.4495.68742.05852.071,101355.59
Upgrade
Property, Plant & Equipment
66.6146.669.0381.3479.1254.85
Upgrade
Goodwill
317.76317.76462.26409.97409.97-
Upgrade
Other Intangible Assets
17.16389.57456.98410.25410.98-
Upgrade
Other Long-Term Assets
10.5410.8415.713.455.763.54
Upgrade
Total Assets
825.471,2601,7461,7672,007413.98
Upgrade
Accounts Payable
15.0616.5915.0612.03113.58
Upgrade
Accrued Expenses
20.8521.5144.7434.5839.2719.23
Upgrade
Current Portion of Long-Term Debt
3-0.491.841.61-
Upgrade
Current Portion of Leases
0.710.039.598.897.714.33
Upgrade
Current Unearned Revenue
14.8613.8616.3430.510.988.72
Upgrade
Other Current Liabilities
5.284.318.8175.51.152.64
Upgrade
Total Current Liabilities
59.7566.395.03263.3471.7138.5
Upgrade
Long-Term Debt
646.44647.49892.24896.68896.07-
Upgrade
Long-Term Leases
52.0814.9131.6141.0749.9737.67
Upgrade
Long-Term Unearned Revenue
5.715.95.531.7925.051.57
Upgrade
Other Long-Term Liabilities
-19.2520.31.3173.190.75
Upgrade
Total Liabilities
763.98753.851,0451,2041,21678.49
Upgrade
Common Stock
0.30.290.270.230.220.19
Upgrade
Additional Paid-In Capital
2,6782,6552,5402,1002,0101,372
Upgrade
Retained Earnings
-2,617-2,149-1,839-1,532-1,218-1,037
Upgrade
Comprehensive Income & Other
0.270.420.22-4.77-1.090.09
Upgrade
Shareholders' Equity
61.49506.59701.3562.9790.99335.49
Upgrade
Total Liabilities & Equity
825.471,2601,7461,7672,007413.98
Upgrade
Total Debt
702.22672.43933.93948.48955.3642
Upgrade
Net Cash (Debt)
-387.49-282.5-302.51-176.1689.05276.82
Upgrade
Net Cash Growth
-----67.83%-
Upgrade
Net Cash Per Share
-1.34-1.03-1.19-0.780.441.58
Upgrade
Filing Date Shares Outstanding
300.37297.85267.95247.08221.18193.1
Upgrade
Total Common Shares Outstanding
300.35294.42267.74226.51220.98192.29
Upgrade
Working Capital
353.64429.38647.02588.741,029317.09
Upgrade
Book Value Per Share
0.201.722.622.493.581.74
Upgrade
Tangible Book Value
-273.44-200.74-217.94-257.32-29.97335.49
Upgrade
Tangible Book Value Per Share
-0.91-0.68-0.81-1.14-0.141.74
Upgrade
Machinery
-69.1368.0360.8649.839.78
Upgrade
Construction In Progress
-2.281.344.72.30.14
Upgrade
Leasehold Improvements
-33.7735.2334.1331.1129.93
Upgrade
Order Backlog
-31.218.7---
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q